SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
6 Months Ended |
|
|
|
|
Jun. 30, 2020
USD ($)
$ / shares
shares
|
May 04, 2020
USD ($)
$ / shares
shares
|
Apr. 29, 2020
USD ($)
$ / shares
shares
|
Feb. 06, 2020
$ / shares
|
Dec. 26, 2019
shares
|
Dec. 19, 2019
shares
|
Apr. 29, 2019
USD ($)
$ / shares
shares
|
Apr. 25, 2019
$ / shares
shares
|
Mar. 18, 2019
USD ($)
$ / shares
shares
|
Jul. 13, 2018
USD ($)
shares
|
Jun. 30, 2020
USD ($)
$ / shares
shares
|
Jun. 30, 2019
USD ($)
shares
|
Mar. 31, 2019
shares
|
Jun. 30, 2020
USD ($)
$ / shares
segment
shares
|
Jun. 30, 2019
USD ($)
shares
|
Jul. 22, 2020
USD ($)
|
Feb. 12, 2020
$ / shares
|
Dec. 31, 2019
$ / shares
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shelf registration maximum equity offering price | $ |
|
|
|
|
|
|
|
|
|
$ 175,000,000
|
|
|
|
|
|
|
|
|
| Sale of stock, stockholders aggregate shares available-for-sale (in shares) |
|
|
|
|
|
|
|
|
|
13,990,403
|
|
|
|
|
|
|
|
|
| Sale of stock, shares issuable upon exercise of warrant (in shares) |
|
|
|
|
|
|
|
|
|
2,051,771
|
|
|
|
|
|
|
|
|
| Number of shares issued in transaction (in shares) |
|
|
|
|
|
|
4,318,272
|
|
4,181,068
|
|
|
|
|
|
|
|
|
|
| Number of securities called by each warrant (in shares) |
|
|
|
|
|
|
|
3,897,010
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share (in usd per share) | $ / shares |
|
|
|
|
|
|
$ 2.025
|
|
$ 2.33
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock | $ |
|
|
|
|
|
|
$ 7,900,000
|
|
$ 9,700,000
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants or rights (in usd per share) | $ / shares |
|
|
$ 0.10
|
|
|
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par or stated value per share (in dollars per share) | $ / shares |
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
| Restriction period |
|
|
|
|
|
|
|
45 days
|
|
|
|
|
|
|
|
|
|
|
| Purchase price of each additional warrant (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
$ 0.125
|
|
|
|
|
|
|
|
|
|
|
| Exercise commencement period |
|
|
|
|
|
|
|
6 months
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of common stock and warrants | $ |
|
|
$ 1,200,000
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 20,706,919
|
|
|
|
| Issuance of common stock and warrants (in shares) |
|
|
12,230,418
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued per warrant (in shares) |
|
|
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par or stated value per share (in dollars per share) | $ / shares |
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
| Proceeds from issuance of preferred stock and warrants | $ |
|
$ 22,600,000
|
|
|
|
|
|
|
|
|
|
|
|
$ 22,560,994
|
0
|
|
|
|
| Proceeds from issuance of preferred stock and warrants, net. | $ |
|
$ 19,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise of warrants (in shares) |
|
|
|
|
3,593,714.4
|
|
|
|
|
|
1,847,309
|
|
|
1,847,309
|
|
|
|
|
| Warrants, accumulated gross unrealized gain | $ |
$ 1,729,200
|
|
|
|
|
|
|
|
|
|
$ 1,729,200
|
|
|
$ 1,729,200
|
|
|
|
|
| Change in fair value of warrant liabilities | $ |
|
|
|
|
|
|
|
|
|
|
1,058,700
|
$ 1,812,800
|
|
2,637,500
|
2,669,800
|
|
|
|
| Warrant inducement expense | $ |
|
|
|
|
|
|
|
|
|
|
6,467,048
|
0
|
|
7,157,887
|
0
|
|
|
|
| General and administrative expense | $ |
|
|
|
|
|
|
|
|
|
|
5,659,721
|
3,049,711
|
|
$ 7,329,528
|
$ 6,164,206
|
|
|
|
| Antidilutive securities excluded from computation of earnings per share (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
53,955,496
|
24,542,552
|
|
|
|
| Number of operating segments | segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
| Patent Costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General and administrative expense | $ |
|
|
|
|
|
|
|
|
|
|
$ 108,000
|
$ 126,000
|
|
$ 193,000
|
$ 287,000
|
|
|
|
| Short-term Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by each warrant (in shares) |
|
|
|
|
|
|
|
|
4,181,068
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
|
|
1 year
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants or rights (in usd per share) | $ / shares |
|
|
$ 0.10
|
|
|
|
|
|
$ 4.00
|
|
|
|
|
|
|
|
$ 0.10
|
|
| Extension period |
|
|
|
6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term Warrants | Measurement Input, Exercise Price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding, measurement input | $ / shares |
0.10
|
|
|
|
|
|
|
|
|
|
0.10
|
|
|
0.10
|
|
|
|
|
| Long-term Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by each warrant (in shares) |
|
|
|
|
|
|
|
|
2,508,634
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants or rights (in usd per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 2.56
|
|
|
|
|
|
|
|
|
|
| Long-term Warrants | Measurement Input, Exercise Price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding, measurement input | $ / shares |
0.10
|
|
|
|
|
|
|
|
|
|
0.10
|
|
|
0.10
|
|
|
|
|
| Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants or rights (in usd per share) | $ / shares |
|
|
|
|
|
|
$ 2.13
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in shares) |
1,539,424
|
|
|
|
2,994,762
|
5,441,023
|
4,318,272
|
|
|
|
1,539,424
|
|
|
1,539,424
|
|
|
|
|
| Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants or rights (in usd per share) | $ / shares |
|
|
|
|
|
|
$ 2.53
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in shares) |
|
|
|
|
|
|
215,914
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent fees | $ |
|
|
|
|
|
|
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred offering costs | $ |
|
|
|
|
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
|
| Exchange Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued per warrant (in shares) |
|
|
|
|
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant inducement expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
| Offer to Amend and Exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liabilities | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (1,058,700)
|
|
|
|
|
| Private Placement | Series A Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants or rights (in usd per share) | $ / shares |
|
$ 58.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in shares) |
|
382,779
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant issuable per investment unit (in shares) |
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Broker Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Units warrant units issued (in shares) |
|
8,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Broker Warrants | Series A Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in shares) |
|
10,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gain on exchange of warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 380,600
|
|
|
|
|
| Series A Preferred Stock | Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued in transaction (in shares) |
|
382,779
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issuable per investment unit (in shares) |
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par or stated value per share (in dollars per share) | $ / shares |
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares issuable upon conversion (in shares) |
|
38,277,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series A Preferred Stock | Broker Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares issuable upon conversion (in shares) |
|
2,712,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H.C. Wainwright & Co., LLC and Ladenburg Thalmann & Co., Inc. | At-the-Market Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, ATM maximum equity offering price | $ |
|
|
|
|
|
|
|
|
|
$ 40,000,000
|
|
|
|
|
|
|
|
|
| Number of shares issued in transaction (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
705,714
|
|
|
|
| SunTrust Robinson Humphrey | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, ATM maximum equity offering price | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 40,000,000
|
|
|
| Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Significant Accounting Policies Disclosure [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock and warrants (in shares) |
|
|
|
|
|
|
|
|
|
|
42,695,948
|
4,318,272
|
4,886,782
|
|
|
|
|
|
| Conversion of preferred stock to common stock (in shares) |
38,277,900
|
|
|
|
|
|
|
|
|
|
38,277,900
|
|
|
|
|
|
|
|